LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 73.76 | 771.67 | 12738 | 10851 | 1.1738 | 1.0858 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 73.76 | 771.67 | 11594 | 10851 | 1.0684 | 1.0350 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 76.02 | 771.67 | 13200 | 11106 | 1.1885 | 1.0918 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 76.02 | 771.67 | 11866 | 11106 | 1.0684 | 1.0347 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 78.25 | 771.67 | 13464 | 11367 | 1.1844 | 1.0891 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 78.25 | 771.67 | 12264 | 11367 | 1.0788 | 1.0395 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 80.48 | 771.67 | 13928 | 11685 | 1.1920 | 1.0916 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 80.48 | 771.67 | 12656 | 11685 | 1.0831 | 1.0411 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.69 | 771.67 | 14192 | 11974 | 1.1852 | 1.0878 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.69 | 771.67 | 12914 | 11974 | 1.0785 | 1.0386 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.92 | 771.67 | 14629 | 12266 | 1.1926 | 1.0902 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.92 | 771.67 | 13315 | 12266 | 1.0855 | 1.0415 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.14 | 771.67 | 14928 | 12592 | 1.1855 | 1.0863 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.14 | 771.67 | 13682 | 12592 | 1.0865 | 1.0416 | MN20160304_L01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 2.49 | 771.67 | 1056 | 867 | 1.2169 | 5.3781 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 2.49 | 771.67 | 938 | 867 | 1.0810 | 2.1676 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 4.71 | 771.67 | 1142 | 956 | 1.1941 | 2.5470 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 4.71 | 771.67 | 1055 | 956 | 1.1031 | 1.7460 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 6.94 | 771.67 | 1254 | 1045 | 1.1999 | 2.0328 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 6.94 | 771.67 | 1173 | 1045 | 1.1224 | 1.6036 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.16 | 771.67 | 1379 | 1138 | 1.2112 | 1.8143 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.16 | 771.67 | 1240 | 1138 | 1.0892 | 1.3288 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.56 | 771.67 | 1562 | 1280 | 1.2197 | 1.6246 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.56 | 771.67 | 1372 | 1280 | 1.0714 | 1.1978 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 13.78 | 771.67 | 1720 | 1459 | 1.1783 | 1.3906 | MN20160304_L01 | J06 |